Mackenzie Financial Corp Has $2.45 Million Holdings in Chemed Co. (NYSE:CHE)

Mackenzie Financial Corp decreased its position in Chemed Co. (NYSE:CHE - Free Report) by 25.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,629 shares of the company's stock after selling 1,580 shares during the quarter. Mackenzie Financial Corp's holdings in Chemed were worth $2,452,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new stake in Chemed in the 4th quarter valued at $42,023,000. Charles Schwab Investment Management Inc. boosted its position in shares of Chemed by 10.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company's stock valued at $72,149,000 after acquiring an additional 13,394 shares during the period. Tokio Marine Asset Management Co. Ltd. acquired a new position in shares of Chemed in the fourth quarter valued at about $8,138,000. Capital Insight Partners LLC grew its stake in shares of Chemed by 5.3% in the fourth quarter. Capital Insight Partners LLC now owns 10,633 shares of the company's stock valued at $5,633,000 after acquiring an additional 539 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in Chemed by 36.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,406 shares of the company's stock worth $1,804,000 after acquiring an additional 914 shares during the period. Institutional investors own 95.85% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on CHE. Royal Bank of Canada boosted their price objective on shares of Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a report on Monday, April 28th. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Insider Activity at Chemed

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the transaction, the executive vice president now owns 14,627 shares of the company's stock, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,500 shares of company stock valued at $4,401,120 over the last three months. 3.29% of the stock is owned by insiders.

Chemed Stock Down 0.4%

Shares of NYSE:CHE traded down $2.34 during trading on Tuesday, reaching $568.05. 74,504 shares of the company traded hands, compared to its average volume of 103,227. The firm has a market capitalization of $8.31 billion, a PE ratio of 28.70, a PEG ratio of 2.15 and a beta of 0.59. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The company's 50 day moving average is $578.97 and its two-hundred day moving average is $565.98.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping the consensus estimate of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. Chemed's revenue was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.20 earnings per share. As a group, research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be given a dividend of $0.50 per share. The ex-dividend date is Thursday, May 29th. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. Chemed's dividend payout ratio is 9.74%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.